In gastric cancer cells, selective inhibition using AUKRA significantly reduced NF-κB activity in human gastric cancer samples and mouse epithelial cells, which in turn inhibited the activation of inflammatory signaling pathways in cancer [43]. Here, NFKB1 is linked to gastric cancer.